Though histopathology remains the ‘‘gold standard’’ for the diagnosis of CIN, both low and high-grade, biomarkers like Ki-67 and P16INK4a have emerged as helpful adjuncts. The gene discussed is CDKN2A; the disease is cervical squamous intraepithelial neoplasia.